Erik Muther

Quality Outlook

2024 Quality Outlook Revealed: Insights from 2023 Fall Conferences

02/02/2024

Tom Valuck , MD, JD;

Erik Muther ;

Theresa Schmidt , MA, PMP, CSPO;

Danny Bellet , MBA;

Donna Dugan , PhD, MS;

David Sloan , PhD;

This past fall, leaders from the Real Chemistry Market Access team attended key quality-related events to understand trends and learn from other quality and value experts.

This past fall, leaders from the...

02/02/2024

Journal of Clinical Pathways

Quality Outlook

A Tale of Two States: Examining the Best and Worst Performing States for HPV Vaccination

02/12/2024

Anne DiSalvo , MPH, MBA;

Kendall Logan , MPH;

Erik Muther ;

Tom Valuck , MD, JD;

This blog post is the last in a three-part series exploring the disparities related to human papilloma virus (HPV) vaccination rates in the US.

This blog post is the last in a...

02/12/2024

Journal of Clinical Pathways

Quality Outlook

Saving Lives from Preventable Cancer: Solutions for Geographic Disparities in HPV Vaccination

10/03/2023

Tom Valuck , MD, JD;

Anne DiSalvo , MPH, MBA;

Kendall Logan , MPH;

Erik Muther ;

This is the first of a 3-part blog series that explores issues related to HPV vaccination rates in the US. In this blog, vaccination disparities are explored among the highest and lowest performing states.

This is the first of a 3-part...

10/03/2023

Journal of Clinical Pathways

Quality Outlook

Saving Lives from Preventable Cancer: Solutions for Racial and Ethnic Disparities in HPV Vaccination

11/10/2023

Tom Valuck , MD, JD;

Anne DiSalvo , MPH, MBA;

Kendall Logan , MPH;

Erik Muther ;

This is the second part of a 3-part blog series that explores issues related to HPV vaccination rates in the US. In this blog, the racial and ethnic disparities in HPV vaccination are explored.

This is the second part of a...

11/10/2023

Journal of Clinical Pathways